(Total Views: 258)
Posted On: 04/15/2023 9:19:55 PM
Post# of 7982
The only value I’m hoping is for RecoveryRx to be insurance covered standard care to hospitals globally with Viant / Synergy behind it.
The players are in place for this to hopefully happen. I can’t see Kelly going alone to market BEIL
Current sales and 25 billion outstanding does not concern me one bit.
We already know that they have a $50.00 target price for RecoveryRx. That 25 billion outstanding shares will be chicken feed compared to the Billions of $$$$ revenues that can be generated.
Viant knows what BIELS has and that is why Sree made the move to Viant.
My gut feeling there is a plan in place, I could be wrong
Sometimes you have to read between the lines.
Why did Paul K mistakenly send a email about a company being sold? Why is a lawyer and not a tax accountant after filing 2 extensions looking over tax returns.
Making sure that all the T’ s are crossed and all the dots are dotted are done for contract agreements.
I could be reading to much into it, but just trying to be hopeful.
JMHO !!
All the best to you my friend.
Zattnt
The players are in place for this to hopefully happen. I can’t see Kelly going alone to market BEIL
Current sales and 25 billion outstanding does not concern me one bit.
We already know that they have a $50.00 target price for RecoveryRx. That 25 billion outstanding shares will be chicken feed compared to the Billions of $$$$ revenues that can be generated.
Viant knows what BIELS has and that is why Sree made the move to Viant.
My gut feeling there is a plan in place, I could be wrong
Sometimes you have to read between the lines.
Why did Paul K mistakenly send a email about a company being sold? Why is a lawyer and not a tax accountant after filing 2 extensions looking over tax returns.
Making sure that all the T’ s are crossed and all the dots are dotted are done for contract agreements.
I could be reading to much into it, but just trying to be hopeful.
JMHO !!
All the best to you my friend.
Zattnt
(2)
(0)Scroll down for more posts ▼
